Home › Funds › Arrowstreet Capital › BSX
Arrowstreet Capital position in BSX
BOSTON SCIENTIFIC CORP · Health Care
Latest position (Q2 2026)23.29M sh
Reported value held$994.18M
Portfolio Weight0.44%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 881.72K | $38.26M | New |
| Q4 2021 | 3.27M | $139.04M | Add |
| Q1 2022 | 5.43M | $240.53M | Add |
| Q2 2022 | 7.54M | $281.00M | Add |
| Q3 2022 | 7.85M | $303.93M | Add |
| Q4 2022 | 8.48M | $392.42K | Add |
| Q1 2023 | 8.53M | $426.88K | Add |
| Q2 2023 | 8.89M | $481.12K | Add |
| Q3 2023 | 7.64M | $403.23K | Reduce |
| Q4 2023 | 6.05M | $349.62K | Reduce |
| Q1 2024 | 4.90M | $335.73K | Reduce |
| Q2 2024 | 4.81M | $370.76K | Reduce |
| Q3 2024 | 5.11M | $427.80M | Add |
| Q4 2024 | 5.59M | $499.47M | Add |
| Q1 2025 | 6.75M | $681.41M | Add |
| Q2 2025 | 6.53M | $701.38M | Reduce |
| Q3 2025 | 8.37M | $816.91M | Add |
| Q4 2025 | 11.04M | $1.05B | Add |
| Q1 2026 | 13.89M | $871.70M | Add |
| Q2 2026 | 23.29M | $994.18M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BSX
- Vanguard Group 139.69M sh · $13.32B · Q4 2025
- BlackRock Inc 129.68M sh · $5.53B · Q2 2026
- Fidelity Management & Research (FMR) 45.70M sh · $1.95B · Q2 2026
- MFS Investment Management 24.86M sh · $1.50B · Q2 2026
- Geode Capital Management 33.44M sh · $1.42B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Norges Bank Investment Management 21.17M sh · $903.54M · Q2 2026
- Two Sigma Investments 19.42M sh · $828.86M · Q2 2026
- Goldman Sachs Group 19.21M sh · $819.79M · Q2 2026
- Morgan Stanley 18.95M sh · $808.66M · Q2 2026